// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Dance for people with chronic respiratory disease: A qualitative study

Keir Philip - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The five-repetition sit-to-stand test (5STS in patients with bronchiectasis: validity and reponsiveness

Suhani Patel - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Barriers to Exercise in Difficult Asthma in the WATCH Cohort

Anna Freeman - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Measuring the experience of living with COPD and receiving medical care in people with COPD

Marcie A Jones - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Depression

N/A

What should Pulmonary Rehabilitation (PR look like for people with post-tuberculosis lung disease (PTBLD in Kyrgyzstan?

Maamed Mademilov - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Chest pains among chronic lung disease patients before and after a pulmonary rehabilitation programme; implementation in four countries on three continents

Sanne van Kampen - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

N/A

Can a COPD pharmacist reduce out-patient clinic non-attendance rates?

Maeve Savage - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD: A qualitative exploratory study of patients’ needs following discharge

Bedor Alkhathlan - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Evidence for pulmonary rehabilitation in chronic respiratory diseases in sub-Saharan Africa: a systematic review

Fanuel Bickton - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The opinions of people living with chronic respiratory disease (CRD and healthcare professionals (HCPs about Pulmonary Rehabilitation (PR in Kyrgyzstan

Azamat Akylbekov - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Opinion and practice of pulmonary rehabilitation amongst health care providers in selected areas of Sri Lanka

Chamilya Perera - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Late Breaking Abstract - ‘Shielding’: Patient experience of measures to reduce risk of COVID-19 in those with pre-existing respiratory conditions

Andrew Cumella - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Coronavirus disease

N/A

What Tools and Resources do Pulmonary Rehabilitation Teams use to Deliver Education?

Nicola J. Roberts - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Internet access and usage in patients with chronic respiratory disease

Oliver Polgar - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Home-based exercise training(HET post-hospitalisation for acute exacerbation of COPD(AECOPD - a mixed-method systematic review

Ruth Barker - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

A comparison of 3 sets of paediatric reference values for Cardio-Pulmonary Exercise Testing using cycle ergometry

Paul Burns - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An RER of 1.05 should not be used to determine maximal effort during CPET

Max Thomas - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of peak heart rate achievable using arm ergometry versus leg ergometry

Joanna Shakespeare - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of oxygen uptake obtained using arm and leg cycle ergometry

Joanna Shakespeare - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of anaerobic threshold obtained using arm and leg cycle ergometry

Joanna Shakespeare - European Respiratory Society (ERS) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved